Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Long-Term Deferred Tax (2020 - 2023)

Historic Long-Term Deferred Tax for MDxHealth (MDXH) over the last 4 years, with Q4 2023 value amounting to $10.8 million.

  • MDxHealth's Long-Term Deferred Tax fell 214.33% to $10.8 million in Q4 2023 from the same period last year, while for Dec 2023 it was $10.8 million, marking a year-over-year decrease of 214.33%. This contributed to the annual value of $10.8 million for FY2023, which is 214.33% down from last year.
  • As of Q4 2023, MDxHealth's Long-Term Deferred Tax stood at $10.8 million, which was down 214.33% from $11.0 million recorded in Q4 2022.
  • In the past 5 years, MDxHealth's Long-Term Deferred Tax registered a high of $52.2 million during Q4 2020, and its lowest value of $7.3 million during Q4 2021.
  • In the last 4 years, MDxHealth's Long-Term Deferred Tax had a median value of $11.0 million in 2022 and averaged $24.9 million.
  • Per our database at Business Quant, MDxHealth's Long-Term Deferred Tax crashed by 8612.2% in 2021 and then soared by 5185.49% in 2022.
  • Quarter analysis of 4 years shows MDxHealth's Long-Term Deferred Tax stood at $52.2 million in 2020, then tumbled by 86.12% to $7.3 million in 2021, then skyrocketed by 51.85% to $11.0 million in 2022, then fell by 2.14% to $10.8 million in 2023.
  • Its Long-Term Deferred Tax was $10.8 million in Q4 2023, compared to $11.0 million in Q4 2022 and $43.4 million in Q2 2022.